BRVE Braveheart Bio, Inc.
$21.87▲ +2.01%
Healthcare
Other
Volume 101.2K
Avg Volume (10D) 260.9K
Key Metrics & Fundamentals
Market Cap
$1.97B
P/E Ratio
–
Div Yield
0.00%
52W Range
17.86 - 32.00
% vs 50 MA
-8.91%
% vs 200 MA
–%
RSI-14
50.9
MACD Histogram
+0.5000
Beta (1Y vs SPY)
-0.21
Free Cash Flow
-$16.94M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$15.88M
COGS
–
Operating Exp
$15.88M
Operating Income
-$15.88M
EBIT
-$15.88M
Pretax Income
-$14.99M
Net Income
-$14.99M
EPS (Diluted)
-0.25
Price & Volume History
Loading chart…
Recent News
Braveheart Bio to Participate in Stifel Cardiometabolic Forum
GlobeNewswire · Sep 16, 2026 4:30 PM ET
Braveheart Bio Q2 Net Loss Widens
MT Newswires · Sep 8, 2026 4:29 PM ET
Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Sep 8, 2026 4:03 PM ET
The Market Barely Knows These 2 IPO Stocks — Goldman Sachs Says ‘Buy’
TipRanks · Sep 8, 2026 2:01 PM ET
Braveheart Bio to Participate in Cantor Global Healthcare Conference
GlobeNewswire · Sep 1, 2026 4:30 PM ET
Insiders Are Betting Big on These 3 Healthcare Stocks
MarketBeat · Aug 31, 2026 1:20 PM ET
Deere upgraded, Lumentum initiated: Wall Street's top analyst calls
The Fly · Aug 31, 2026 9:45 AM ET
Jefferies starts biopharma firm Braveheart at Buy after IPO
Investing.com · Aug 31, 2026 7:00 AM ET
Braveheart Bio (BRVE) Raised $382.5 Million In Its IPO
Simply Wall St. · Aug 11, 2026 4:08 PM ET
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire · Aug 7, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BRVE's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.